Informatie:
Fout:
ID
29420
Beschrijving
Effect of Enteral Nutrition Rich in Eicosapentaenoic Acid (EPA) on Patients Receiving Chemotherapy for GI Tumor; ODM derived from: https://clinicaltrials.gov/show/NCT01048463
Link
https://clinicaltrials.gov/show/NCT01048463
Trefwoorden
Versies (1)
- 22-03-18 22-03-18 -
Houder van rechten
See clinicaltrials.gov
Geüploaded op
22 maart 2018
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Gastric Cancer NCT01048463
Eligibility Gastric Cancer NCT01048463
- StudyEvent: Eligibility
Similar models
Eligibility Gastric Cancer NCT01048463
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Radical excision Stomach Carcinoma | Radical excision Colorectal Carcinoma
Item
the cases have undergone radical excision on gastric cancer or colorectal cancer.
boolean
C0184918 (UMLS CUI [1,1])
C0699791 (UMLS CUI [1,2])
C0184918 (UMLS CUI [2,1])
C0009402 (UMLS CUI [2,2])
C0699791 (UMLS CUI [1,2])
C0184918 (UMLS CUI [2,1])
C0009402 (UMLS CUI [2,2])
Medical contraindication Absent Chemotherapy
Item
without contraindication for chemotherapy.
boolean
C1301624 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0392920 (UMLS CUI [1,3])
C0332197 (UMLS CUI [1,2])
C0392920 (UMLS CUI [1,3])
Eligibility XELOX Regimen Adjuvant Postoperative
Item
eligible for postoperative adjuvant xelox chemotherapy.
boolean
C1548635 (UMLS CUI [1,1])
C1956962 (UMLS CUI [1,2])
C1522673 (UMLS CUI [1,3])
C0032790 (UMLS CUI [1,4])
C1956962 (UMLS CUI [1,2])
C1522673 (UMLS CUI [1,3])
C0032790 (UMLS CUI [1,4])
Able to swallow food | Able to swallow oral medication
Item
capable of taking in food or drug orally.
boolean
C0566359 (UMLS CUI [1])
C2712086 (UMLS CUI [2,1])
C0175795 (UMLS CUI [2,2])
C2712086 (UMLS CUI [2,1])
C0175795 (UMLS CUI [2,2])
Absence Absorption Dysfunction Severe
Item
without severe absorption dysfunction
boolean
C0332197 (UMLS CUI [1,1])
C0237442 (UMLS CUI [1,2])
C3887504 (UMLS CUI [1,3])
C0205082 (UMLS CUI [1,4])
C0237442 (UMLS CUI [1,2])
C3887504 (UMLS CUI [1,3])
C0205082 (UMLS CUI [1,4])
Informed Consent
Item
able and willing to give written, informed consent
boolean
C0021430 (UMLS CUI [1])
Comorbidity | Hematological Disease | Immune System Diseases | Liver Dysfunction | Renal dysfunction | Metabolic Diseases
Item
comorbidities: diseases of hematology or immunology system; hepatic or renal dysfunction; metabolic diseases.
boolean
C0009488 (UMLS CUI [1])
C0018939 (UMLS CUI [2])
C0021053 (UMLS CUI [3])
C0086565 (UMLS CUI [4])
C3279454 (UMLS CUI [5])
C0025517 (UMLS CUI [6])
C0018939 (UMLS CUI [2])
C0021053 (UMLS CUI [3])
C0086565 (UMLS CUI [4])
C3279454 (UMLS CUI [5])
C0025517 (UMLS CUI [6])
Body mass index
Item
bmi>35kg/m2
boolean
C1305855 (UMLS CUI [1])
Life Expectancy
Item
life expectancy≤3mo
boolean
C0023671 (UMLS CUI [1])
Chemotherapy Palliative
Item
the chemotherapy treatment is palliative.
boolean
C0392920 (UMLS CUI [1,1])
C1285530 (UMLS CUI [1,2])
C1285530 (UMLS CUI [1,2])
Therapeutic radiology procedure Preoperative | Chemotherapy Neoadjuvant Preoperative
Item
the patient has received radiotherapy or neoadjuvant chemotherapy prior to the operation.
boolean
C1522449 (UMLS CUI [1,1])
C0445204 (UMLS CUI [1,2])
C0392920 (UMLS CUI [2,1])
C0600558 (UMLS CUI [2,2])
C0445204 (UMLS CUI [2,3])
C0445204 (UMLS CUI [1,2])
C0392920 (UMLS CUI [2,1])
C0600558 (UMLS CUI [2,2])
C0445204 (UMLS CUI [2,3])